BIOWKS — Bio-Works Technologies AB Income Statement
0.000.00%
Last trade - 00:00
- SEK114.60m
- SEK75.22m
- SEK43.90m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5.57 | 7.23 | 21.9 | 41.3 | 43.9 |
Cost of Revenue | |||||
Gross Profit | 5.37 | 4.22 | 18.6 | 28.8 | 26.8 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 47.7 | 52 | 31.8 | 87.4 | 100 |
Operating Profit | -42.1 | -44.7 | -9.84 | -46.1 | -56.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -42.1 | -45 | -9.37 | -44.7 | -54.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -42.1 | -45 | -12.9 | -45 | -56.8 |
Net Income Before Extraordinary Items | |||||
Net Income | -42.1 | -45 | -12.9 | -45 | -56.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -42.1 | -45 | -12.9 | -45 | -56.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.37 | -1.5 | -0.415 | -1.28 | -1.57 |
Dividends per Share |